Friday 6 November 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
114.97
1.01
−0.87%
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) EBITDA
Hinge Health Inc.'s EBITDA for fiscal 2025 was −$494.2M, compared with $4.5M in fiscal 2024. Over the twelve months to 30 June 2026 it was $161.2M. Hinge Health Inc. ranks 9th of 43 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$494.2M | — |
| FY2024 | $4.5M | — |
| FY2023 | −$115.3M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $61.2M | 23.34% |
| Mar 2026 | $49.6M | 16.13% |
| Dec 2025 | $42.7M | 448.29% |
| Sep 2025 | $7.8M | — |
| 4 more quarters | Free account |
EBITDA against peers
| Company | EBITDA |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $690.0M |
| HQY HealthEquity, Inc. compare | $510.0M |
| WAY Waystar Holding Corp. compare | $444.3M |
| DOCS Doximity, Inc. compare | $218.1M |
| HNGE Hinge Health Inc. | $161.2M |
| PRVA Privia Health Group, Inc. compare | $63.8M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| SDGR Schrodinger, Inc. compare | −$127.8M |
| TEM Tempus AI, Inc. compare | −$166.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement